State AZ
Clinical Trials in Arizona
Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 242 actively recruiting studies with Arizona sites out of 242 registered in total. The busiest research areas in Arizona are Solid Tumor, Prostate Cancer, Obesity. Leading sponsors running trials in the state include Mayo Clinic, University of Arizona, AstraZeneca. By stage, Arizona trials break down as Phase 1 (37), Phase 2 (77), Phase 3 (80), Phase 4 (5).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Arizona
Frequently Asked Questions — Clinical Trials in Arizona
How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 242 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 242. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Prostate Cancer, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Arizona
NCT05244486 N/A
Recruiting
Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Pos...
Condition
Erectile Dysfunction Following Radical Prostatectomy
Enrollment
200 pts
Location
United States
Sponsor
Charitable Union for the Resea
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT04165070 Phase 1, Phase 2
Recruiting
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) ...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
450 pts
Location
United States, Canada, Hungary
Sponsor
Merck Sharp & Dohme LLC
NCT06003166 Phase 2
Recruiting
4-AP Peripheral Nerve Crossover Trial
Condition
Peripheral Nerve Injury
Enrollment
68 pts
Location
United States
Sponsor
University of Arizona
NCT07224373 Phase 1
Recruiting
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
24 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT06883305 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participa...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
990 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07559175 Phase 2
Recruiting
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult P...
Condition
Exocrine Pancreatic Insufficiency (EPI)
Enrollment
66 pts
Location
United States, Bulgaria, Hungary
Sponsor
Aimmune Nestlé Health Science
NCT05137665 N/A
Recruiting
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Ho...
Condition
Amyotrophic Lateral Sclerosis
Enrollment
1,000 pts
Location
United States, Colombia, Puerto Rico
Sponsor
Target ALS Foundation, Inc.
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
NCT04799301 Phase 1
Recruiting
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Int...
Condition
Diet Therapy
Enrollment
60 pts
Location
United States
Sponsor
National Institute of Diabetes
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06423911 Phase 3
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Condition
Chronic Myeloid Leukemia
Enrollment
333 pts
Location
United States, Australia, Belgium
Sponsor
Ascentage Pharma Group Inc.
NCT06911632 N/A
Recruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring ...
Condition
Pulmonary Hypertension
Enrollment
900 pts
Location
United States
Sponsor
Tempus AI
NCT05521698 Phase 1
Recruiting
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
80 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT05034432 Phase 4
Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventri...
Condition
Arrythmia
Enrollment
100 pts
Location
United States
Sponsor
University of Rochester
NCT06406114 Phase 2
Recruiting
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Condition
Drug Allergy
Enrollment
300 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06508463 Phase 1
Recruiting
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lympho...
Condition
Peripheral T Cell Lymphoma
Enrollment
21 pts
Location
United States
Sponsor
Mayo Clinic
NCT06450106 Phase 1
Recruiting
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
Condition
Prostate Cancer
Enrollment
18 pts
Location
United States, Australia
Sponsor
SURGE Therapeutics
NCT04688190 N/A
Recruiting
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
Condition
Mitral Regurgitation
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Universitätsklinikum Hamburg-E
NCT06585410 Phase 3
Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous S...
Condition
Cutaneous Squamous Cell Carcinoma (CSCC)
Enrollment
369 pts
Location
United States, Australia
Sponsor
Regeneron Pharmaceuticals
NCT07589634 Phase 2
Recruiting
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Relea...
Condition
Multiple Myeloma
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT05204888 N/A
Recruiting
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Condition
COPD
Enrollment
642 pts
Location
United States, Canada
Sponsor
Temple University
NCT06734351 Phase 3
Recruiting
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adu...
Condition
Mid Face Volume Deficit
Enrollment
231 pts
Location
United States
Sponsor
AbbVie
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology